Olsalazine in Patients Intolerant of Sulphasalazine

Abstract

Fifty patients with ulcerative colitis, intolerant of sulphasalazine, were treated with 500 mg olsalazine twice daily for a 3-month trial period. Thirty-eight of the patients (76%) tolerated the drug well, and all continued to take it beyond the 3-month period. Twelve (24%) were withdrawn because of side effects, the commonest being diarrhoea. There were no haematologic or biochemical abnormalities. Thus, olsalazine is a useful drug for patients who are intolerant of sulphasalazine.

References

Page 1

	Year	Citations
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE A K Azad Khan, J Piris, S. C. Truelove The Lancet Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	1977	821
Absorption, metabolism, and excretion of salicylazosulfapyridine in man Hasse Schröder, Dag E. S. Campbell Clinical Pharmacology & Therapeutics Fecal ExcretionPharmaceutical SciencePharmaceutical ChemistryMedicinal ChemistryPharmacological Study	1972	325
5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans Sten Nørby Rasmussen, S Bondesen, E Hvidberg, Gastroenterology Health SciencesBiochemistryGastrointestinal PharmacologyFood DigestionPhysiology	1982	225
Reversible male infertility due to sulphasalazine: studies in man and rat. Colm O’Morain, Paul Smethurst, Caroline J Doré, Gut	1984	223
Azodisal sodium in the treatment of ulcerative colitis Hanna Sandberg–Gertzén, Gunnar Järnerot, Wolfgang Kraaz Gastroenterology MedicineGastroenterologyPharmacotherapyUlcerative ColitisPharmacology	1986	191
Incidence of sulphasalazine-induced male infertility. G G Birnie, T I McLeod, G Watkinson Gut	1981	180
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. C P Willoughby, J K Aronson, H Agback, Gut Medicinal ChemistryAnti-inflammatoryPharmacological StudyBiochemistryGastrointestinal Pharmacology	1982	152
Colonic Azodisalicylate Metabolism Determined by In Vivo Dialysis in Healthy Volunteers and Patients With Ulcerative Colitis K. Lauritsen, J.P. Hart Hansen, M. Ryde, Gastroenterology BiochemistryMedicinePharmacologyGastroenterologyDigestive Tract	1984	141
Olsalazine in active ulcerative colitis. Warwick Selby, G. D. Barr, A. Ireland, BMJ InflammationAnti-inflammatory AgentsFunctional Gastrointestinal DisorderGastrointestinal PharmacologyPlacebo Capsules	1985	116
Absorption and Excretion of a Single 1-g Dose of Azodisal Sodium in Subjects with Ileostomy Hanna Sandberg–Gertzén, M. Ryde, Gunnar Järnerot Scandinavian Journal of Gastroenterology Azodisal SodiumGastrointestinal PharmacologyMedicineGastroenterologyUseful Drug	1983	71

Page 1